Alzheimer Disease, Early Onset Clinical Trial
Official title:
The Effects and Mechanisms of Theta-burst Stimulation on Cognitive Function in the Patients With Biomarker-defined Young-onset Alzheimer's Disease Dementia
Young-onset dementia (YOD) is a devastating condition, and it produces substantial psychosocial impacts on individual's functioning and family's care burden. Alzheimer's disease (AD) dementia is the most common type in YOD. Medication treatment Response was limited and unsatisfactory. In recent years, repetitive transcranial magnetic stimulation (rTMS) has been considered an alternative for the improvement of cognition in older patients with cognitive impairment. This study aims to examine the effects and potential mechanisms of theta-burst stimulation (TBS) on cognitive function in individuals with young-onset AD.
The investigators apply the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria to recruit the biomarker-defined, young-onset AD patients with intermediate-to-high levels of biological evidence. This is a randomized, sham-controlled, 2-way crossover study, and combined neuroimaging study of 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) to further explore the potential mechanisms. This study will consist of two intervention periods. A total of 50 young-onset AD patients will be consecutively recruited and be randomized into one of two groups: active and sham stimulation (n = 25 per group) in every intervention period. Besides, 20 cognitively normal subjects will be recruited for neuroimaging comparison. Cognitive evaluation will be performed before and immediately after treatment at 2 weeks of TBS intervention, and 4 weeks after TBS. Data on functional neuroimaging will be also collected before and after TBS protocol. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03625401 -
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT05983575 -
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
|
Phase 3 | |
Completed |
NCT05989087 -
The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
|
||
Recruiting |
NCT06080659 -
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
|
N/A | |
Not yet recruiting |
NCT06099587 -
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
|
N/A | |
Not yet recruiting |
NCT05604183 -
Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT03514875 -
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
|
N/A | |
Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
Completed |
NCT03706885 -
Efavirenz for Patients With Alzheimer's Disease
|
Phase 1 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Not yet recruiting |
NCT05006599 -
SNIFF - 3-Week Aptar CPS Device
|
Phase 2 | |
Recruiting |
NCT02740634 -
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
|
N/A | |
Active, not recruiting |
NCT03069391 -
The Interactive Physical and Cognitive Exercise System
|
N/A | |
Recruiting |
NCT04701957 -
The Ketogenic Diet for Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06268886 -
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT04100889 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
|
||
Recruiting |
NCT04656860 -
Juice Plus Supplement Clinical Trial
|
N/A | |
Recruiting |
NCT05315895 -
The Dampness Syndrome of Chinese Medicine Cohort Study
|
||
Recruiting |
NCT04916964 -
Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial)
|
N/A | |
Recruiting |
NCT04804618 -
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
|